Deep Brain Stimulation in Tourette Syndrome
Conditions: Tourette Syndrome; Deep Brain Stimulation Interventions: Device: Deep Brain Stimulation Sponsors: University College, London; National Institute for Health Research, United Kingdom; University College London Hospitals; Northern Care Alliance NHS Foundation Trust; St George ' s University Hospitals NHS Foundation Trust; Royal Devon and Exeter NHS Foundation Trust; University of Bristol; University of Dundee; London School of Hygiene and Tropical Medicine; King ' s College London; University Hospital, Rouen; Imperial College London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)
Conditions: Human African Trypanosomiasis Interventions: Drug: Treatment of seropositive individuals (positive serology test, but parasitology not confirmed) Sponsors: Drugs for Neglected Diseases; Institute of Tropical Medicine, Belgium; Institut de Recherche pour le Developpement; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; Ministry of Public Health, Democratic Republic of the Congo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
Conditions: Falciparum; Malaria Interventions: Drug: Artemether-lumefantrine; Drug: Dihydroartemisinin-Piperaquine Sponsors: Infectious Diseases Research Collaboration, Uganda; London School of Hygiene and Tropical Medicine; Radboud University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
Conditions: Healthy Interventions: Behavioral: Group 1 (I x S x S x F); Behavioral: Group 2 (O x S x S x F); Behavioral: Group 3 (I x E x S x F); Behavioral: Group 4 (O x E x S x F); Behavioral: Group 5 (I x S x S x M); Behavioral: Group 6 (O x S x S x M); Behavioral: Group 7 (I x E x S x M); Behavioral: Group 8 (O x E x S x M); Behavioral: Group 9 (I x S x D x F); Behavioral: Group 10 (O x S x D x F); Behavioral: Group 11 (I x E x D x F); Behavioral: Group 12 (O x E x D x F); Behavioral: Group 13 (I x S x D x M); Behavioral: Group 14 (O x S x D x M); Behavioral: Group 15 (I x E x D x M); Behavioral: Group 16 (O x E x D x ...
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe
Conditions: Adherence, Medication; HIV Prevention Interventions: Behavioral: Pharmacy-based PrEP refill and gift voucher; Behavioral: Control (Standard of care) Sponsors: University of California, Berkeley; Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe); University of California, San Francisco; Liverpool School of Tropical Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Every Newborn-Reach Up Early Education Intervention for All Children- a Parent Group Intervention for School Readiness in Bangladesh, Nepal, and Tanzania
Conditions: Child Development; Child Development Disorder Interventions: Behavioral: Pre-Primary Intervention Sponsors: London School of Hygiene and Tropical Medicine; International Centre for Diarrhoeal Disease Research, Bangladesh; Golden Community, Nepal; Muhimbili University of Health and Allied Sciences; University of Glasgow Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Evaluation of a disability-inclusive ultra-poor graduation programme in Uganda: study protocol for a cluster-randomised controlled trial with process evaluation
DiscussionDIG is a promising intervention to evaluate for people with disabilities, adapted to be disability inclusive across programme components through extensive consultations and collaboration, and has proven efficacy at reducing poverty in other marginalised groups. However, evaluating a well-evidenced intervention among a new target group poses ethical considerations.Trial registrationRegistry for International Development Impact Evaluations, RIDIE-STUDY-ID-626008898983a (20/04/22). ISRCTN registry,ISRCTN78592382. Retrospectively registered on 17/08/2023. (Source: Trials)
Source: Trials - March 21, 2024 Category: Research Source Type: clinical trials
Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi
Conditions: Chronic Kidney Diseases; Non-Communicable Chronic Diseases; Non-communicable Disease; Kidney Diseases Interventions: Other: No intervention; observational study Sponsors: Liverpool School of Tropical Medicine; Wellcome Trust; Malawi Epidemiology and Intervention Research Unit; London School of Hygiene and Tropical Medicine; University of Glasgow; Malawi-Liverpool-Wellcome Trust Clinical Research Programme Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children
Conditions: Tuberculosis; Pediatric Infectious Disease Interventions: Diagnostic Test: Xpert MTB/RIF Ultra in stools and urine Sponsors: Medecins Sans Frontieres, Spain; Ministry of Health, Guinea-Bissau; Ministry of Health, South Sudan; Institute of Tropical Medicine, University of Tuebingen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
LAssa Fever Adjunct Treatment With DEXamethasone
Conditions: Lassa Fever Interventions: Drug: Dexamethasone; Drug: Ribavirin Sponsors: Bernhard Nocht Institute for Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
Conditions: Decompensated Cirrhosis Interventions: Device: CirrhoCare management system Sponsors: University College, London; CyberLiver Ltd; London School of Hygiene and Tropical Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Conditions: Lassa Fever Interventions: Drug: Favipiravir; Drug: Ribavirin; Drug: Dexamethasone Sponsors: Irrua Specialist Teaching Hospital; Alliance for International Medical Action; University of Bordeaux; Bernhard Nocht Institute for Tropical Medicine; Federal Medical Centre, Owo; Programme PAC-CI, Site ANRS-MIE de C ôte d ' Ivoire; Fondation pour la Recherche Scientifique, Benin; M édecins Sans Frontières, Belgium; Alex Ekwueme Federal University Teaching Hospital; Donka Hospital, Conakry; Centre de Recherche Médicale de Lambaréné; University of Hamburg-Eppendorf; Phebe Hospital, Liberia; University of North Caro...
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Improving access to family planning for women with disabilities in Kaduna city, Nigeria: study protocol for a pragmatic cluster-randomized controlled trial with integrated process evaluation
DiscussionDefining access to services is complex, as it is not a single variable that can be measured directly and need for family planning is subjectively defined. Consequently, we have conceptualized ‘access to family planning’ based on a composite of beliefs about using services if needed.Trial registrationISRCTN registry ISRCTN12671153. Retrospectively registered on 17/04/2023. (Source: Trials)
Source: Trials - January 5, 2024 Category: Research Source Type: clinical trials
Postpartum Primaquine in Breast Milk
Conditions: Postpartum Women Interventions: Drug: Primaquine Sponsors: University of Oxford; Mahidol Oxford Tropical Medicine Research Unit Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control
Conditions: Malaria; Soil Transmitted Helminths; Schistosomiasis; Seasonal Malaria Chemoprevention; Mass Drug Administration With Anthelminthic Drugs Interventions: Drug: Sulphadoxine-pyrimethamine and Amodiaquine Sponsors: London School of Hygiene and Tropical Medicine; Kintampo Health Research Centre, Ghana Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
